Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF
Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF
Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
S3-Leitlinie 091-001 „<strong>Lokaltherapie</strong> <strong>chronischer</strong> <strong>Wun<strong>den</strong></strong> <strong>bei</strong> <strong>den</strong> Risiken CVI, PAVK und Diabetes mellitus“<br />
7. Epub 2010/06/16. Epikutantestung <strong>bei</strong> <strong>Patienten</strong> <strong>mit</strong> Ulcus cruris unter besonderer<br />
Berucksichtigung moderner Wundprodukte.<br />
267. Piaggesi A, Baccetti F, Rizzo L, Romanelli M, Navalesi R, Benzi L. Sodium carboxyl-methylcellulose<br />
dressings in the management of deep ulcerations of diabetic foot. Diabetic Medicine.<br />
2001;18(4):320-4. Epub 2001/07/05.<br />
268. Jude E, Apelqvist, Spraul M, Martini J. Randomized controlled study of diabetic foot ulcers<br />
dressed with hydrofiber© containing ionic silver or calcium alginate dressings. European Wound<br />
Management Association Conference; 2005, 15 17 September; Stuttgart, Germany. 2005;Thur 1730-<br />
1900; V33-4:106.<br />
269. Alexander BR, Murphy KE, Gallagher J, Farrell GF, Taggart G. Gelation time, homogeneity, and<br />
rupture testing of alginate-calcium carbonate-hydrogen peroxide gels for use as wound dressings.<br />
Journal of biomedical materials research Part B, Applied biomaterials. 2011. Epub 2011/11/29.<br />
270. Blair SD, Jarvis P, Salmon M, McCollum C. Clinical trial of calcium alginate haemostatic swabs.<br />
Br J Surg. 1990;77(5):568-70. Epub 1990/05/01.<br />
271. Lalau JD, Bresson R, Charpentier P, Coliche V, Erlher S, Ha V, et al. Efficacy and tolerance of<br />
calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions. Diabetes &<br />
Metabolism. 2002;28(3):223-9.<br />
272. Lindsay G, Latta D, Lyons KGB, Livingstone ED, Thomson W. A study in general practice of the<br />
efficacy of cadexomer iodine in venous leg ulcers treated on alternate days. 1986; 12:141-7. Acta<br />
Therapeutica. 1986;12:7-141.<br />
273. Harcup JW, Saul PA. A study of the effect of cadexomer iodine in the treatment of venous leg<br />
ulcers. BrJClinPract. 1986;40(9):360-4.<br />
274. Steele K, Irwin G, Dowds N. Cadexomer iodine in the management of venous leg ulcers in<br />
general practice. Practitioner. 1986;230(1411):63-8. Epub 1986/01/01.<br />
275. Kero M, Tarvainen K, Hollmen A, Pekanmaki K. A comparison of cadexomer iodine with<br />
dextranomer in the treatment of venous leg ulcers. Current Therapeutic Research 1987;45(5):761-7.<br />
276. Laudanska H, Gustavson B. In-patient treatment of chronic varicose venous ulcers. A<br />
randomized trial of cadexomer iodine versus standard dressings. Journal of International Medical<br />
Research. 1988;16(6):428-35.<br />
277. Skog E, Arnesjo B, Troeng T, Gjores JE, Bergljung L, Gundersen J, et al. A randomized trial<br />
comparing cadexomer iodine and standard treatment in the out-patient management of chronic<br />
venous ulcers. British Journal of Dermatology. 1983;109(1):77-83.<br />
278. Apelqvist J, Ragnarson Tennvall G. Cavity foot ulcers in diabetic patients: a comparative study<br />
of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical<br />
trial. Acta dermato-venereologica. 1996;76(3):231-5. Epub 1996/05/01.<br />
279. Hillstrom L. Iodosorb compared to standard treatment in chronic venous leg ulcers--a<br />
multicenter study. Acta Chirurgica Scandinavica - Supplementum. 1988;544:53-6.<br />
280. Troëng T, Skog E, Arnesjö B, Gjöres JE, Bergljung L, Gundersen J, et al. A randomised<br />
multicentre trial to compare the efficacy of cadexomer iodine and standard treatment in the<br />
management of chronic venous ulcers in out-patients. In: Fox JA, Fisher H, editors. Cadexomer iodine.<br />
Stuttgart: Schattauer; 1983. p. 43-50.<br />
281. Ishibashi Y, Soeda S, Oura T, Nishikawa T, Niimura M, Nakajima H, et al. Clinical Effects of<br />
KCB-1, a Solution of Recombinant Human Basic Fibroblast Growth Factor, on Skin Ulcers: A Phase III<br />
Study Comparing with Sugar and Povidone Iodine Ointment. . Rinsho Iyaku 1996;12(10):2159-87.<br />
282. Vermeulen Hester AU, J. vH. Topical silver for treating infected wounds. Cochrane Database<br />
of Systematic Reviews: Reviews. 2007;Issue 1.<br />
283. Munter KC, Beele H, Russell L, Crespi A, Grochenig E, Basse P, et al. Effect of a sustained<br />
silver-releasing dressing on ulcers with delayed healing: the CONTOP study. Journal of Wound Care.<br />
2006;15(5):199-206.<br />
284. Carter MJ, Tingley-Kelley K, Warriner IRA. Silver treatments and silver-impregnated dressings<br />
for the healing of leg wounds and ulcers: A systematic review and meta-analysis. J Am Acad<br />
Dermatol. 2010;63(4):668-79.<br />
Seite 267 von 279 aktueller Stand: 12.06.2012
Change language